Clinical trial
Memantine Treatment in Alzheimer's Disease Patients Stratified With Behavioral and Psychological Symptoms of Dementia (BPSD) Symptoms and Cognitive Severity: A Multi-center, Open-label, Parallel-group and Prospective Clinical Study
NCT03168997 is registered in ClinicalTrials.gov with Wei Cuibai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Memantine Treatment in Alzheimer's Disease Patients Stratified With Behavioral and Psychological Symptoms of Dementia (BPSD) Symptoms and Cognitive Severity: A Multi-center, Open-label, Parallel-group and Prospective Clinical Study
- Lead sponsor
- Wei Cuibai
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 15, 2017
- Completion date
- December 31, 2018
- Enrollment
- 222 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.